Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

St. Jude Medical Applauds MADIT-CRT Trial
St. Jude Medical, Inc. (NYSE: STJ) commends the efforts of investigators in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). The early results of the trial indicate that early intervention with CRT-D therapy can slow a patient"s progression from early stage heart failure (NYHA Class I-II) to late stage heart failure (NYHA Class III-IV).
generic viagra online
Dems Prepare For Health Reform Cost Analysis While Courting GOP Votes
What is sure to be a staggering price tag for health reform has Senate Democrats talking about changing the chamber"s normal accounting procedures, The Hill reports.
News of the day
Laparoscopic Radical Versus Partial Nephrectomy For Tumors >4cm: Intermediate-term Oncologic And Functional Outcomes
UroToday.com - Nephron-sparing surgery has become the well-accepted method for treating patients with localized tumor disease of the kidney. Laparoscopic partial nephrectomy (LPN) has evolved such that it is considered equivalent to open partial nephrectomy for tumors 4 cm. They had 110 patients with Stage T1b-T3N0M0 renal cell carcinoma treated with LRN (N=75) or LPN (N=35). As expected the LRN group had larger tumors and more T3a tumors with clear cell pathologic features. The median follow up was 57 months in the LRN group and 44 months in the LPN group. There was no difference between the two treatment groups with regards to overall mortality, cancer-specific mortality, or recurrence rates. However, the LPN group had significantly less reduction in estimated glomerular filtration rate compared to the LRN group. None of the LPN group patients developed second stage chronic kidney disease compared to 12% in the LRN group.
Nutrition

American Society of Health-System Pharmacists Awards Viso-Gurovich Honorary Membership

The American Society of Health-System Pharmacists (ASHP) has named Fela Viso-Gurovich, Ph.D., an honorary member of the Society for her pioneering work in the development of hospital pharmacy in Mexico. Dr. Viso-Gurovich received the honor during ASHP"s Summer Meeting in Rosemont, Ill. Dr. Viso-Gurovich is a professor at the University of the State of Hidalgo in Pachuca, Hidalgo, Mexico. In 1998, she, along with a group of students, began the first pharmaceutical services in a pediatric hospital in Mexico. She was the driving force in the creation of the Mexican Association of Hospital Pharmacists (MAHP) and served as it first president; currently, she directs international affairs for MAHP. At the University of the State of Hidalgo, she teaches pharmacotherapy, ethics, and pharmaceutical legislation. Her research interests are in pharmacoepidemiology, postmarketing surveillance, and drug utilization. "Dr. Viso-Gurovich"s work at the University of the State of Hidalgo and with the MAHP has transformed the practice of pharmacy in Mexico," said ASHP President Kevin J. Colgan, M.A., FASHP. "We are pleased to recognize her groundbreaking efforts with this award." For six years, Dr. Viso-Gurovich served as director of Mexico"s national pharmacopeia, which is an activity of the federal government. She is also one of the founders of the North American Compact for the Advancement of Hospital Pharmacy, a collaboration of MAHP, ASHP, and the Canadian Society of Hospital Pharmacists. In 2007, the North American Compact and the Ministry of Health of the State of Hidalgo conducted an invitational conference in Pachuca for public health and university officials throughout Mexico on the future of hospital pharmacy in the country. That conference, which drew lessons from the development of hospital pharmacy in Canada and the United States, led to federal government support for hospital implementation of pharmacy services under the direction of a qualified pharmacist. Dr. Viso-Gurovich earned her pharmacy degree and her Ph.D. in biochemistry from the National Polytechnic Institute, Mexico City, and studied pharmacology as a postdoctoral student at Cambridge University in England. American Society of Health-System Pharmacists


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009